1. Home
  2. YPF vs NVO Comparison

YPF vs NVO Comparison

Compare YPF & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YPF Sociedad Anonima

YPF

YPF Sociedad Anonima

HOLD

Current Price

$49.17

Market Cap

206.0B

Sector

Energy

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$47.21

Market Cap

208.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YPF
NVO
Founded
1977
1923
Country
Argentina
Denmark
Employees
N/A
69500
Industry
Integrated oil Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.0B
208.2B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
YPF
NVO
Price
$49.17
$47.21
Analyst Decision
Buy
Hold
Analyst Count
3
11
Target Price
$45.67
$51.00
AVG Volume (30 Days)
1.1M
10.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
3.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.39
N/A
Revenue Next Year
N/A
$3.70
P/E Ratio
N/A
$13.60
Revenue Growth
N/A
N/A
52 Week Low
$22.82
$35.12
52 Week High
$57.49
$64.16

Technical Indicators

Market Signals
Indicator
YPF
NVO
Relative Strength Index (RSI) 48.80 41.94
Support Level $33.57 $45.62
Resistance Level $56.82 $46.92
Average True Range (ATR) 1.52 1.40
MACD -0.21 -0.73
Stochastic Oscillator 20.64 25.13

Price Performance

Historical Comparison
YPF
NVO

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. The company operates through four business segments: Upstream, Midstream and Downstream, LNG and Integrated Gas, and New Energies. The Upstream segment focuses on the exploration and production of crude oil and natural gas. The Midstream and Downstream segment includes refining, transportation, and commercialization of crude oil, refined, and petrochemical products. The LNG and Integrated Gas segment is involved in natural gas transportation, processing, storage, and commercialization. The New Energies segment focuses on energy transition initiatives, including natural gas distribution, power generation, renewable energy, and related technology development. It generates majority of revenue from Midstream and Downstream segment.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: